ConductScience.org, home

Gene · 506

ATP5F1B: ATP synthase F1 subunit beta

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ATP5F1B: ATP synthase F1 subunit beta. Genes, record 506. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/506

On this page

Gene

Symbol
ATP5F1B
HGNC
Name
ATP synthase F1 subunit beta
HGNC
NCBI Gene ID
506
NCBI Gene
HGNC ID
HGNC:830
HGNC
Ensembl
ENSG00000110955
NCBI Gene
Aliases
ATP5B, ATPMB, ATPSB, DYT38, HEL-S-271, HUMOP2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P06576ATP synthase F(1) complex subunit beta, mitochondrial5299Ensembl, GeneID, HGNC

Source UniProt

Patents58

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1438103P06576Espacenet
EP 4650780 A22025-11-191999P06576Espacenet
EP 4641201 A22025-10-291571P06576Espacenet
JP 2025517969 A2025-06-121571P06576Espacenet
JP 2025517970 A2025-06-121999P06576Espacenet
JP 2025062604 A2025-04-147041P06576Espacenet
US 11860162 B22024-01-021510P06576Espacenet
US 11702671 B22023-07-1850P06576Espacenet
US 11694765 B22023-07-04354P06576Espacenet
US 11446398 B22022-09-207041P06576Espacenet

1 to 10 of 58

See all 58 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,081

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleATP5F1B papersNewest fiscal year
R01AG011085Ubiquitin‐mediated proteolysis and cell cycle control42025
P30CA008748Cancer Center Support Grant32025
R01EY010804Setting the Stage for Replacement of Mitochondrial Genes32025
P01CA092584Structural Cell Biology of DNA Repair Machines22025
P20GM103449Vermont Biomedical Research Network-Vermont INBRE22025
P30CA010815Consolidated Basic Cancer Research Program22025
P30CA016086Cancer Center Support Grant22025
P30CA016359Cancer Center Support Grant22025
P30CA046592University of Michigan Rogel Cancer Center Support Grant 2023-202822025
P30CA068485Cancer Center Support Grant22025

1 to 10 of 1,081Source NIH's project files

See all 1,081 nih grants

Papers1,666

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Ion-Responsive Microneedles Delivering Subtype-Specific Mitochondrial Extracellular Vesicles from HEY1⁺ Cardiomyocytes for Cardiac Repair in Bama Minipigs with Myocardial Ischemia-Reperfusion Injury.Theranostics202642370197PubTator, text miningPubMed
Gene Expression Alterations in Peripheral Blood Mononuclear Cells and Cartilage Explants from End-Stage Rheumatoid Arthritis Patients in Response to Taurine: A Pilot Exploratory Study.Life (Basel)202642195348PubTator, text miningPubMed
Vertebral BMSC-EVs under estrogen deficiency drive senescence-related mitochondrial dysfunction in endplate chondrocytes via MRPL1 mRNA delivery.Exp Mol Med202642098460PubTator, text miningPubMed
Autoantibodies Predictive of Atherosclerosis Progression and Statin Response in Juvenile-Onset SLE: A Biomarker Discovery Study.medRxiv202642051571PubTator, text miningPubMed
Contrasting Dispersal Patterns of Co-Occurring Benthic Sister Sea Star Labidiaster Species (Asteroidea: Heliasteridae) in the Southern Ocean.Ecol Evol202641970346PubTator, text miningPubMed
ATP5B Expression as a Prognostic Biomarker in Solid Tumors: A Systematic Review and Meta-Analysis.Anticancer Agents Med Chem202641926307PubTator, text miningPubMed
C-terminus-outward orientation of SARS-CoV-2 envelope proteins on viral capsid enables a novel virus-cell interaction pathway.Front Cell Infect Microbiol202641909841PubTator, text miningPubMed
Mitochondrial impairment and mTORC1 signalling exhaustion define NK Cell dysfunction progression in melanoma.Cancer Immunol Immunother202641843165PubTator, text miningPubMed
Common and Distinct Features in Serum Proteomic Profiles in Keratoconus, Post-Laser Vision Correction Ectasia, and Pellucid Marginal Degeneration.Invest Ophthalmol Vis Sci202641810891PubTator, text miningPubMed
Conserved non-coding RNA motifs influence the neuropathogenicity of Simbuviruses: Molecular dissection in the Schmallenberg virus model.PLoS Pathog202641805942PubTator, text miningPubMed

1 to 10 of 1,666

See all 1,666 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/506

GET https://conductscience.org/api/genes/v1/506/patents?page=2